Stay updated on Pegcetacoplan in C3 Glomerulopathy: Clinical Trial
Sign up to get notified when there's something new on the Pegcetacoplan in C3 Glomerulopathy: Clinical Trial page.

Latest updates to the Pegcetacoplan in C3 Glomerulopathy: Clinical Trial page
- Check6 days agoChange DetectedThe page shows a revision tag updated from v3.5.3 to v3.5.4, indicating a newer revision of the page or its documentation rather than a substantive content change.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision tag on the page was updated to v3.5.3 from v3.5.2, indicating a new revision of the page content.SummaryDifference0.0%

- Check27 days agoChange DetectedNo changes were detected (no additions or deletions provided).SummaryDifference0.0%

- Check34 days agoChange DetectedRevision label updated from v3.5.0 to v3.5.2 on the page.SummaryDifference0.0%

- Check42 days agoChange DetectedThe study location entry now shows Padova, Italy 35128 instead of Padua, Italy 35128. This aligns the listing with the local city name.SummaryDifference0.0%

- Check49 days agoChange DetectedAdded Mesangiocapillary glomerulonephritis, type II to the study's condition terms.SummaryDifference0.0%

Stay in the know with updates to Pegcetacoplan in C3 Glomerulopathy: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pegcetacoplan in C3 Glomerulopathy: Clinical Trial page.